[Chronic outcome of percutaneous transcatheter patent foramen ovale closure with Left-disk-coated patent foramen ovale occluder].
OBJECTIVE
To investigate the safety and efficacy of patent foramen ovale (PFO) closure with Left-disk-coated PFO occluder.


METHODS
The device was implanted in patients with PFO under the guidance of fluoroscopy and transthoracal echocardiography using a 10-12 French delivery sheath via femoral vein approach. Aspirin (100 mg/d for 6 months) was administered post procedure. Patients were followed clinically and echocardiographically at 24 hours, 1 month, 3 months, 6 months, and 12 months after device implantation and yearly thereafter.


RESULTS
Permanent device implantation failed in one patient (4%) and succeed in the remaining 24 patients (96%). There were no major in-hospital-adverse events or complications (thromboembolism, occluder dislodgement, infection or myocardial infarction). Seven patients developed transient atrial premature beats or atrial tachycardia during implantation and stopped without medication post procedure. Follow-up [(25 + or - 12) months] results showed that all occluders were in position and there were no residual shunt, arrhythmia and cerebral vessel events post procedure.


CONCLUSIONS
Left-disk-coated PFO occluder is safe and effective for PFO closure.
Huang
Yi-gao
YG
Department of Cardiology, Guangdong General Hospital, Guangzhou 510100, China.
Zhang
Cao-jin
CJ
Huang
Xin-sheng
XS
Huang
Tao
T
Huang
Wen-hui
WH
D000293:Adolescent; D000328:Adult; D006328:Cardiac Catheterization / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D054092:Foramen Ovale, Patent / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D055815:Young Adult